Sternal Closure Systems Market Report and Forecast 2025-2034

The global sternal closure systems market was valued at USD 2.50 Billion in 2024, driven by the increasing incidence of cardiothoracic surgeries across the globe. The market is anticipated to grow at a CAGR of 5.10% during the forecast period of 2025-2034 to achieve a value of USD 4.11 Billion by 2034.

Sternal Closure Systems Market Overview

Sternal closure systems are medical devices used to stabilise and secure the sternum after cardiothoracic surgeries, such as open-heart procedures. These systems, including wires, plates, screws, cables, and bone cement, ensure proper sternal alignment and healing, reducing complications like sternal dehiscence and infections. Advanced materials like titanium and stainless steel enhance durability and biocompatibility. Innovations such as 3D-printed implants and bioabsorbable materials are improving patient outcomes. With the rising prevalence of cardiovascular diseases and surgical interventions, sternal closure systems are essential in post-operative recovery and long-term chest stability.

Sternal Closure Systems Market Growth Drivers

Innovative Fixation Systems Strengthening the Market Growth

The rising prevalence of cardiothoracic surgeries and increasing adoption of advanced fixation technologies are key drivers of market expansion. The growing awareness of postoperative complications has led to a demand for stronger, more reliable closure solutions. For instance, in August  2024, DePuy Synthes, a division of Johnson & Johnson MedTech, introduced the MatrixSTERNUM Fixation System, featuring low-profile plates and enhanced locking strength for improved sternal stability. This innovation is expected to enhance surgical outcomes, reduce postoperative complications, and boost market adoption. As hospitals prioritise efficient closure solutions, this development will significantly contribute to the global sternal closure systems market growth in the coming years.

Increasing Demand for Advanced Suture Technologies to Enhance the Sternal Closure Systems Market Value

The demand for stronger, more durable sternal closure solutions is increasing due to rising open-heart surgeries and the need to reduce postoperative risks such as sternal dehiscence. For instance, in March  2023, Able Medical Devices launched Valkyrie Looped Sternotomy Sutures, which double the surface area of traditional sutures, providing greater sternal stability. Available in various needle configurations, these sutures improve surgical efficiency and patient recovery. As hospitals and surgical centres seek more effective closure techniques, these innovations will drive adoption, enhance clinical outcomes, and contribute to the global sternal closure systems market expansion during the forecast period.

Sternal Closure Systems Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Technological Advancements Transforming the Market

The integration of 3D printing, biocompatible materials, and robotic-assisted surgery is revolutionising the market. These advancements enhance implant precision, durability, and post-surgical recovery. Customised implants, tailored to individual patient anatomy, are reducing complications and improving surgical outcomes. Additionally, the use of bioabsorbable materials is gaining traction, minimising long-term foreign body reactions. Robotics and AI-assisted surgery are streamlining procedures, increasing efficiency and accuracy. As these technologies continue to evolve, they are expected to drive market growth, offering safer and more effective solutions for sternal fixation in cardiothoracic surgeries worldwide.

Rising Cardiothoracic Surgeries Incidence to Fuel Sternal Closure Systems Market Growth

The increasing prevalence of cardiovascular diseases and thoracic surgeries is significantly boosting the demand for sternal closure systems. Factors such as ageing populations, sedentary lifestyles, and rising obesity rates contribute to a higher incidence of coronary artery disease and heart failure, necessitating more open-heart surgeries. The growing adoption of minimally invasive procedures has also led to advancements in sternal fixation techniques, improving patient outcomes. As the global burden of cardiovascular diseases rises, the demand for secure, durable, and effective sternal closure solutions will continue to expand, propelling market growth over the forecast period.

Adoption of Titanium-Based Implants to Increase Sternal Closure Systems Market Demand

Titanium-based implants are gaining widespread preference due to their superior biocompatibility, strength, and corrosion resistance compared to traditional materials like stainless steel. Titanium plates and screws provide enhanced stability, reduced infection risks, and faster healing, making them ideal for sternal fixation in high-risk patients. The growing focus on lightweight and high-performance materials is driving technological advancements in implant design. Additionally, increased regulatory approvals and product innovations are boosting market adoption. As surgeons and hospitals prioritise safety and longevity, the demand for titanium-based sternal closure systems is expected to dominate the market in the coming years.

Rise in Strategic Partnerships Policies to Influence the Sternal Closure Systems Market Size Positively

The growing demand for advanced sternal closure solutions and the rising number of cardiac surgeries are key drivers of market growth. Additionally, the adoption of innovative materials like carbon fibre is transforming sternal fixation. For instance, in January  2024, a strategic partnership was announced between ARC Group Medical and a leading distributor for the exclusive distribution of STERN FIX across the United States. This FDA 510(k)-cleared carbon fibre sternal stabilisation system offers enhanced rigidity post-sternotomy. The collaboration is expected to boost product availability, accelerate market penetration, and strengthen the market growth in the forecast period.

Sternal Closure Systems Market Segmentation

Sternal Closure Systems Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type

• Closure Devices
• Wires
• Plates and Screws
• Cables
• Others
• Bone Cement

Market Breakup by Material

• Titanium
• Stainless Steel
• Polyether Ether Ketone (PEEK)

Market Breakup by Procedure

• Median Sternotomy
• Hemisternotomy
• Bilateral Thoracsternotomy

Market Breakup by End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Sternal Closure Systems Market Share

Closure Devices to Dominate the Segment by Product Type

Closure devices, particularly wires, plates, and screws, are poised to hold the largest market share due to their high adoption in cardiac surgeries, superior strength, and reduced infection risks. Increasing cardiothoracic surgeries, trauma cases, and technological advancements in fixation techniques drive demand. Plates and screws offer better stability and faster healing, making them the preferred choice. Moreover, rising minimally invasive procedures and improvements in biocompatible materials are fostering market expansion. As healthcare infrastructure improves globally, closure devices will continue to dominate the market due to their proven clinical efficacy and widespread application in sternotomy procedures.

Titanium to Hold a Significant Sternal Closure Systems Market Value for Segmentation by Material

Titanium is expected to lead the market due to its biocompatibility, corrosion resistance, and high mechanical strength, making it the material of choice for sternal closure systems. It offers better patient outcomes by reducing infection risks, enhancing healing, and providing long-term stability. The increasing number of cardiac surgeries and innovations in titanium-based implants further fuel demand. Additionally, rising R&D investments and advancements in 3D printing technology are making titanium implants more customisable and accessible. With a growing elderly population requiring cardiac interventions, titanium-based systems will continue to dominate the market due to their superior clinical benefits.

Median Sternotomy to Hold a Considerable Sternal Closure Systems Market Share by Procedure

Median sternotomy is projected to hold the largest market share as it remains the gold standard for open-heart surgeries, coronary artery bypass grafting (CABG), and valve replacements. The technique provides maximum surgical exposure, ease of access, and effective closure, making it essential in complex procedures. Rising cases of cardiovascular diseases, technological advancements in sternotomy closure techniques, and increasing healthcare spending further bolster its demand. Additionally, improvements in post-surgical recovery and infection control measures are enhancing its adoption. As cardiac surgeries continue to rise globally, median sternotomy remains a key driver of market growth due to its proven surgical efficacy.

Hospitals and Clinics to Leading the Sternal Closure Systems Market by End User

Hospitals and clinics are expected to dominate the market due to their high patient influx, advanced surgical facilities, and availability of skilled cardiac surgeons. Increasing government investments in healthcare infrastructure, expansion of cardiac care units, and the growing burden of cardiovascular diseases drive demand for sternal closure systems in hospitals. Additionally, rising insurance coverage and reimbursement policies are making complex cardiac surgeries more accessible. As hospitals adopt cutting-edge technologies, personalised implants, and minimally invasive procedures, they will continue to lead the market, offering superior patient care and advanced treatment options for sternal closure surgeries.

Sternal Closure Systems Market Analysis by Region

North America is set to lead the market, driven by a high prevalence of cardiovascular diseases, advanced medical infrastructure, and strong regulatory support for innovative technologies. For instance, in January  2022, Evonik Venture Capital invested in CircumFix Solutions, a Tennessee-based start-up developing a novel sternal closure device made from high-performance polymers. This investment highlighted the growing R&D and material innovation in sternal fixation. Europe remains a key player, benefiting from government funding and technological progress, while Asia Pacific experiences rapid growth due to medical tourism and ageing demographics.

Leading Players in the Sternal Closure Systems Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Arthrex Inc.

Established in 1981, Arthrex Inc. is headquartered in Naples, Florida, USA. The company specialises in developing and manufacturing orthopaedic medical devices and surgical solutions. With a strong focus on minimally invasive procedures, Arthrex provides advanced implants, instruments, and biologics used in orthopaedics, sports medicine, and trauma surgery. Its sternal closure systems offer innovative fixation techniques, enhancing post-surgical stability and recovery. Committed to continuous medical education and research, Arthrex supports healthcare professionals worldwide, ensuring cutting-edge advancements in patient care and surgical techniques across various medical disciplines.

Zimmer Biomet

Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare, offering orthopaedic implants, surgical robotics, and regenerative medicine solutions. Its sternal closure systems feature high-quality titanium and stainless steel implants, ensuring optimal bone healing and post-operative stability. With a strong focus on R&D, the company continues to develop personalised solutions for orthopaedic and cardiovascular procedures. In December  2020, Zimmer Biomet acquired A&E Medical Corporation, expanding its sternal closure portfolio with sutures, cable systems, and rigid fixation devices, alongside single-use pacing wire and surgical punch products. This acquisition strengthens Zimmer Biomet’s presence in cardiovascular surgery, enhancing patient outcomes worldwide.

Johnson & Johnson

Established in 1886, Johnson & Johnson is headquartered in New Brunswick, New Jersey, USA. As a multinational healthcare conglomerate, the company operates through pharmaceuticals, medical devices, and consumer health divisions. Its medical devices sector includes cutting-edge sternal closure systems designed for cardiothoracic surgeries, ensuring optimal fixation and post-operative recovery. Johnson & Johnson continues to redefine surgical innovation with biocompatible materials, 3D printing, and digital surgical solutions. With a strong commitment to patient safety and medical advancement, the company plays a pivotal role in enhancing surgical procedures and improving healthcare access globally.

Medicon eG

Founded in 1941, Medicon eG is headquartered in Tuttlingen, Germany, a renowned hub for medical technology. The company specialises in surgical instruments, implants, and fixation systems, catering to orthopaedic, spinal, and cardiovascular procedures. Its sternal closure systems feature high-precision plating and wiring solutions, ensuring secure and reliable post-surgical fixation. Medicon eG is known for its rigorous quality control, innovation, and craftsmanship, making it a preferred choice among surgeons and healthcare institutions worldwide. Through continuous product development, the company enhances surgical efficiency and patient safety, contributing to the evolution of modern medical device technology.

KLS Martin Group

Established in 1896, KLS Martin Group is headquartered in Tuttlingen, Germany, and is a leading provider of surgical instruments, implants, and medical technology solutions. The company’s sternal closure systems integrate biocompatible materials and advanced fixation techniques, enhancing cardiothoracic surgical outcomes. With a strong focus on research, precision engineering, and digital surgery solutions, KLS Martin delivers high-quality implants and devices for orthopaedic, maxillofacial, and cardiovascular surgeries. Its commitment to customised surgical solutions, education, and training ensures surgeons worldwide have access to state-of-the-art technologies, driving global advancements in medical and surgical practices.

Other key players in the market include CARDIOLINK Group, Kinamed Incorporated, Acumed LLC, and B. Braun SE.

Key Questions Answered in the Sternal Closure Systems Market

• What was the global sternal closure systems market value in 2024?
• What is the global sternal closure systems market forecast outlook for 2025-2034?
• What is market segmentation based on product type?
• What is market segmentation based on material?
• What is market segmentation based on procedures?
• What is market segmentation based on end user?
• What are the major factors aiding the global sternal closure systems market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major global sternal closure systems market trends?
• Which product type will lead the market segment?
• Which materials will lead the market segment?
• Which procedures will lead the market segment?
• Which end user will lead the market segment?
• Who are the key players involved in the global sternal closure systems market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?